Literature DB >> 12036017

Flavanone and flavonol glycosides from the leaves of Thevetia peruviana and their HIV-1 reverse transcriptase and HIV-1 integrase inhibitory activities.

Supinya Tewtrakul1, Norio Nakamura, Masao Hattori, Tamio Fujiwara, Tanomjit Supavita.   

Abstract

Two new flavanone glucosides, (2R)- and (2S)-5-O-beta-D-glucopyranosyl-7,4'-dihydroxy-3',5'-dimethoxyflavanone[pervianoside I (3), peruvianoside II(4)] and a new flavonol glycoside, quercetin 3-O-[beta-D-glucopyranosyl-(1-->2)-[alpha-L-rhamnopyranosyl-(1-->6)]-beta-D-galactopyranoside] (peruvianoside III, 13) were isolated from the leaves of Thevetia peruviana Schum., together with nine known flavonol glycosides and two known iridoid glucosides. The structures of all compounds were determined on the basis of chemical and spectroscopic methods. Their inhibitory effects against HIV-1 reverse transcriptase and HIV-1 integrase were also investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036017     DOI: 10.1248/cpb.50.630

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  9 in total

1.  Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.

Authors:  Tetsuro Hisayoshi; Mayu Shinomura; Kanta Yokokawa; Ikumi Kuze; Atsushi Konishi; Kumi Kawaji; Eiichi N Kodama; Keishi Hata; Saori Takahashi; Satoru Nirasawa; Shohei Sakuda; Kiyoshi Yasukawa
Journal:  J Nat Med       Date:  2015-02-08       Impact factor: 2.343

2.  Novel urushiols with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity from the leaves of Rhus verniciflua.

Authors:  Kazunari Kadokura; Kohei Suruga; Tsuyoshi Tomita; Wataru Hiruma; Motoyuki Yamada; Akio Kobayashi; Akira Takatsuki; Toshiyuki Nishio; Tadatake Oku; Yoshihiro Sekino
Journal:  J Nat Med       Date:  2014-10-28       Impact factor: 2.343

3.  Ethanolic extract of Thevetia peruviana flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways.

Authors:  Chittima Managit; Hiroaki Sakurai; Ikuo Saiki
Journal:  Oncol Lett       Date:  2017-02-17       Impact factor: 2.967

4.  Novel 3'-Processing Integrase Activity Assay by Real-Time PCR for Screening and Identification of HIV-1 Integrase Inhibitors.

Authors:  Supachai Sakkhachornphop; Weeraya Thongkum; Chatchai Tayapiwatana
Journal:  Biomed Res Int       Date:  2015-05-07       Impact factor: 3.411

5.  Comparative study of the effects of diosmin and diosmetin on fat accumulation, dyslipidemia, and glucose intolerance in mice fed a high-fat high-sucrose diet.

Authors:  Sangwon Chung; Hyo-Jin Kim; Hyo-Kyoung Choi; Jae Ho Park; Jin-Taek Hwang
Journal:  Food Sci Nutr       Date:  2020-09-20       Impact factor: 2.863

6.  FT-NIR spectroscopy and RP-HPLC combined with multivariate analysis reveals differences in plant cell suspension cultures of Thevetia peruviana treated with salicylic acid and methyl jasmonate.

Authors:  Dary Mendoza; Juan Pablo Arias; Olmedo Cuaspud; Orlando Ruiz; Mario Arias
Journal:  Biotechnol Rep (Amst)       Date:  2020-08-12

7.  Antifungal efficacy of Thevetia peruviana leaf extract against Alternaria solani and characterization of novel inhibitory compounds by Gas Chromatography-Mass Spectrometry analysis.

Authors:  Bhanu Raj Meena; Sanjeev Meena; Deepali Chittora; Kanika Sharma
Journal:  Biochem Biophys Rep       Date:  2021-01-17

Review 8.  Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.

Authors:  Mohammad Amin Khazeei Tabari; Amin Iranpanah; Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

9.  Effect of salicylic acid and methyl jasmonate in the production of phenolic compounds in plant cell suspension cultures of Thevetia peruviana.

Authors:  Dary Mendoza; Olmedo Cuaspud; Juan Pablo Arias; Orlando Ruiz; Mario Arias
Journal:  Biotechnol Rep (Amst)       Date:  2018-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.